ViiV Healthcare presented 1Semester 2010 Best Selling Drugs, all HIV drugs with leading sales by Epzicom/KivexaAbacavir + Lamivudine (3TC)HIV,Combivir Lamivudine + ZidovudineHIV
Agenerase/LexivaAmprenavir/Fosamprenavir HIV.

QTR; Ex-Stiefel Labs 1 Semester 2010 Best Selling Drugs, with Zovirax(Acyclovir) to treat herpes, followed by
Bactroban(Muporicin antibiotic) and Duac(Clindoc) to treat acne.

Actelion Ltd. presented 1 Semester 2010 Best Selling Drugs, with Tracleer(Bosentan)to treat Pulmonary Arterial Hypertension, followed by Ventavis(Iloprost) also to treat Pulmonary Arterial Hypertension and also followed by Zavesca(Miglustat) to treat Niemann-Pick type C.

QTR, Johnson & Johnson Inc. presented 1 Semester Best Selling Drugs, with Remicade(Infliximab)Rheumatoid Arthritis, and Eprex/Procrit(Epoetin Alfa) to treat EPO/Anemia, with Risperdal Consta(RisperidoneAtypical) Antypshychotic.

Forest Labs presented 1Q 2010 best selling drugs, with Lexapro (Escitalopra) MajorDepressiveDisorder/Generalized Anxiety Disorder, followed by Namenda(Memantine) to treat Alzheimer and
Bystolic(Nebivolol) Antihypertensive.

QLT Inc. presented 1Q 2010 earnings, with Visudyne (Verteporfin) drug to treat macular degeneration.

Celgene Corp. presented 1Q 2010 earnings, with Revlimid(Lenalidomide) to treat multiple myeloma, followed by
Vidaza (Azacitidine) for myelodysplastic syndrome.

Jazz Pharmaceuticals Inc.presented 1Q 2010 earnings with narcolepsy drug Xyrem (Sodium Oxybate), followed by anxiety disorder treatment drug Luvox CR (Fluvoxamine), 2008 and 2009 comparative chart.

Nycomed A/S presented 2009 earnings, with heartburn drug Pantazol/Controloc (Pantoprazole) followed by Calcium D3 (Calcium Carbonate) 2008 comparative.

Eisai Co. presented 1Q 2010 earnings, with Alzheimer drug Aricept (Donepezil) followed by heartburn drug Pariet/Aciphex (Rabeprazole) nausea and chemotherapy drug Aloxi (Palonosetron)

Astellas Phama presented 4Q 2009 earnings, with Prograf (Tacrolimus) to treat prophylaxis of organ rejection, followed by Hamal/Flomax (Tamsulosin) to treat benign prostatic hyperplasia, and Lipitor(Atorvastatin) Statin /Cholesterol.

Daiichi Sankyo Co. presented 2009 earnings, with Benicar/Olmetec(Olmesartan) drug for Hypertension,
Loxonin (Loxoprofen) Inflamation/Pain followed by
Mevalotin(Pravastatin) Statin.

Takeda Pharmaceutical Industries, presented 4Q 2009 earanings, with Actos(Pioglitazone) drug to treat Diabetes Type 2 followed by Blopress (Candesartan) drug to trat Hypertension and Prevacid (Lansoprazole) for Heartburn.

Shinogi & Co. presented 4Q 2009 best selling drugs, with Crestor(Rosuvastatin) drug, follwed by Flomox (Cefcamate)Antibiotic.

Cubist Pharmaceuticals Inc. presented 1Q 2010 earnings, with Cubici(Daptomycin) (IV)Antibiótic.

Kyowa Hakko Kirin Co. presented 4Q 2009 earnings, with Nesp/Espo (Japan)Darbepoetin Alfa/Epoetin Alfa drug to treat Renal Anemia, followed by Allelock (Japan)
Olopatadine (Oral)drug to treat Conjunctivitis.

Spectrum Pharmaceuticals Inc., presented 1Q 2010 earnings, with Zevalin (Ibritumomab) drug to treat No Hodkgin lymphoma as top seller.

Shire Plc. presented 1Q 2010 earnings, with Vyvanse(Lisdexamfetamine) to treat ADHD, followed by Elaprase (Idursulfase) forHunter Syndrome, and Adderall XR(Amphetamine + Dextroamphetamine) also to treat ADHD.

Lundbeck A/S presented 1Q 2010 earnings, with Cipralex(Escitalopram)Antidepressive drug and Lexapro(Escitalopram) also an Antidepressive drug, followed by
Ebixa(Memantine) to treat Alzheimer.

Onyx Pharmaceuticals Inc. presented 1Q 2010 earnings, with Nexavar(Sorafenib) to treat Renal Cancer/Hepatic Cancer. Comparative charts.